We are live on ! Find out more
CLRBW

Cellectar Biosciences, Inc.
CLRBW

Delisted

CLRBW was delisted on the 20th of August, 2019.

Back to rankings

4 hedge funds and large institutions have $5K invested in Cellectar Biosciences, Inc. in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

38% less capital invested

Capital invested by funds: $8K → $5K (-$3K)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$5K – – –
TFS
2
TrustCore Financial Services
Tennessee
– +$143 +1,000 New

CLRBW Hedge Fund Activity: Q4 2017 in Review

4 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q4 2017, worth a combined $5K — down 38% from $8K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CLRBW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q4 2017, up from 3 in Q3 2017.
  • Funds reported $5K of Cellectar Biosciences, Inc. stock for Q4 2017, down 38% quarter-over-quarter.
  • 1 fund opened new Cellectar Biosciences, Inc. positions in Q4 2017 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2017.